For the Inventor, By the Inventor

Enter assignee name

Brussels, Belgium

Ucb Biopharma Sprl

USPTO Granted Patents = 138

CIPO Patents = 10

EPO Patents = 107

Trademarks = 20

Forward Citations = 732

Loading Chart...

Loading Chart...

242 inventors (with patents filed for the assignee):

Martin John McLoughlin (23 out of 31 patents)

Victoria Elizabeth Jackson (22 out of 22 patents)

Boris Kroeplien (20 out of 25 patents)

4. Kerry Louise Tyson (18 out of 38 patents)

5. John Robert Porter (17 out of 66 patents)

6. Ralph Adams (15 out of 39 patents)

7. Michael James David Heald (15 out of 21 patents)

8. David Paul Humphreys (13 out of 45 patents)

9. Alastair David Griffiths Lawson (13 out of 37 patents)

10. Daniel Christopher Brookings (13 out of 37 patents)

11. Helene Margaret Finney (12 out of 24 patents)

12. Ilario Melzi (12 out of 33 patents)

13. Kevin Richard Lozeau (12 out of 18 patents)

14. Eric Freitag (11 out of 41 patents)

15. Zhaoning Zhu (11 out of 71 patents)

Core Competencies:

Autoinjector Devices

Monomeric Antibody Fab-dsFv

Tau-binding Antibodies

Multispecific Antibodies

Bispecific Antibodies

Neutralising Antibodies

Protein Aggregation Inhibitors

Transdermal Therapeutic Systems

FCRN Specific Antibodies

Imidazothiazole Derivatives

Biological Products

Kinase Inhibitors

138 patents: Sort by Forward Citations

1. 11517676 - Assembly for an autoinjector device (2022-12-06),

2. 11331438 - Cap for an injector (2022-05-17),

3. 11324896 - Cap for an injector (2022-05-10),

4. 11220547 - Antibodies specific to FCRN (2022-01-11),

5. 11059820 - Crystalline forms of seletalisib (2021-07-13),

6. 10889640 - Tau-binding antibodies (2021-01-12),

7. 10829565 - Method for increasing the percentage of monomeric antibody Fab-dsFv multimeric species (2020-11-10),

8. 10828366 - Method of monomerisation of recombinant antibody molecules (2020-11-10),

9. 10774152 - Molecules with specificity for CD45 and CD79 (2020-09-15),

10. 10759844 - Disulfide stabilised antibodies and fragments thereof (2020-09-01),

11. 10752676 - Neutralising antibodies to the major exotoxins TCDA and TCDB of (2020-08-25),

12. 10639424 - Auto-injector and drive unit therefor (2020-05-05),

13. 10639423 - Auto-injector and drive unit therefor (2020-05-05),

14. 10626143 - Method of protein manufacture (2020-04-21),

15. 10618979 - Multispecific antibodies (2020-04-14),

UCB BioPharma SPRL is a global biopharmaceutical company that focuses on discovering and developing innovative medicines and solutions to improve the lives of people with severe diseases of the immune system or the central nervous system. With a mission to transform patients' lives, UCB dedicates itself to advancing medical science, understanding patient needs, and delivering innovative solutions that address unmet medical needs.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 23 2025

138 Patents

#10 in Brussels

#36 in Belgium

#5,705 in the World

Brussels, Belgium

Ucb Biopharma Sprl

Forward Citations = 732

242 inventors:

Martin John McLoughlin (23 out of 31 patents)

Victoria Elizabeth Jackson (22 out of 22 patents)

Boris Kroeplien (20 out of 25 patents)

4. Kerry Louise Tyson (18 out of 38 patents)

5. John Robert Porter (17 out of 66 patents)

Please report any incorrect information to support@idiyas.com

Loading…